World first for consumer cannabinoids as UK’s FSA releases list of permitted CBD products


The UK has become the first country in the world to regulate the market for safe, orally consumed legal cannabis extracts, following the release today of the Food Standards Agency’s public list of cannabinoid (CBD) products permitted for sale to consumers. Publication of the list – a key stage on the path to full authorisation, expected in 2023 – follows two years of close co-operation between the FSA and the Association for the Cannabinoid Industry (ACI), the UK’s CBD sector trade body. Only those CBD products featured on the list have been given


the green light by the FSA to stay on the market, in line with the UK’s Novel Food requirements. Products not included must now be removed from shelves. Steve Moore, ACI founder, commented: “The FSA public list represents a major milestone for the UK’s CBD category.


It demonstrates the progress the sector has made to meet compliance requirements and creates greater


regulatory


certainty which, in turn, will increase levels of consumer trust, encourage investment in the sector, and promote innovation. ACI is immensely grateful for the work that our members and the FSA have put in to take this momentous step.” CBD products on the FSA list have been undergoing assessment by the agency in a long and rigorous Novel Food process. This was open to any CBD product designed for oral consumption that was on sale in the UK on or before 13 February 2020, with the deadline for applications set at 31 March 2021. Any product launched after 13 February 2020, or which was not the subject of a dossier submitted by the cut-off date, may not now be sold until full authorisation is granted. Moore said: “We are hugely proud that, through our


consortium study, all members of the ACI have been included on the FSA’s public list, therefore earning the right to continue to be sold within the UK.”


Beneo invests €7.7 million into new warehouse for improved efficiency


BENEO has announced a quadrupling of the storage capacity at its Offstein facility in Germany, to improve its efficiency and strengthen the company’s business contingency


resilience still further. The new high-


bay warehouse, which opened in February, allows for increased storage of BENEO’s crystalline functional carbohydrates Isomalt, Palatinose™ and galenIQ™. With a €7.7 million investment in this fully automated facility, BENEO says it continues to further improve its supply chain robustness and reduces transport. The new 25-metre-high warehouse has a storage capacity of more than 8.500 Euro pallets and is located close to both the packaging and shipment operations at the production site in Offstein. Together with external warehouses worldwide, the addition of storage capacity in Offstein further supports BENEO’s multi-storage strategy for improved business contingency. Furthermore, transport ways are reduced as a larger proportion of functional carbohydrates is now stored on-site than in external warehouses.


KennedysConfection.com Kennedy’s Confection April 2022 11


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44